| Matthew W Mckinley, MD | |
|
1010 Spuce St, Espanola, NM 87532-3456 | |
| (505) 753-7111 | |
| (505) 753-4438 |
| Full Name | Matthew W Mckinley |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 31 Years |
| Location | 1010 Spuce St, Espanola, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720025737 | NPI | - | NPPES |
| PENDING | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 98-115 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Los Alamos Visiting Nurse Service, Inc | Los alamos, NM | Home health agency |
| Presbyterian Espanola Hospital | Espanola, NM | Hospital |
| Los Alamos Medical Center | Los alamos, NM | Hospital |
| Presbyterian Santa Fe Medical Center | Santa fe, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Espanola Sports Medicine Pa | 2163691411 | 64 |
| Presbyterian Healthcare Services | 9234041708 | 1099 |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
Researchers in Oregon have engineered a material that replicates human bone tissue with an unprecedented level of precision, from its microscopic crystal structure to its biological activity.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
Organizing care services is a complex task and a lot of planning goes into ensuring that they operate smoothly.
The Wall Street Journal reports that even though the mandate was delayed requiring businesses with more than 50 employees to provide coverage for their workers, the overhaul is affecting how companies are run.
› Verified 2 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
Researchers in Oregon have engineered a material that replicates human bone tissue with an unprecedented level of precision, from its microscopic crystal structure to its biological activity.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
Organizing care services is a complex task and a lot of planning goes into ensuring that they operate smoothly.
The Wall Street Journal reports that even though the mandate was delayed requiring businesses with more than 50 employees to provide coverage for their workers, the overhaul is affecting how companies are run.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew W Mckinley, MD 5901 Harper Dr, Albuquerque, NM 87109-3587 Ph: (505) 823-8556 | Matthew W Mckinley, MD 1010 Spuce St, Espanola, NM 87532-3456 Ph: (505) 753-7111 |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
Researchers in Oregon have engineered a material that replicates human bone tissue with an unprecedented level of precision, from its microscopic crystal structure to its biological activity.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
Organizing care services is a complex task and a lot of planning goes into ensuring that they operate smoothly.
The Wall Street Journal reports that even though the mandate was delayed requiring businesses with more than 50 employees to provide coverage for their workers, the overhaul is affecting how companies are run.
› Verified 2 days ago
Herbert V Rachelson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Espanola Multi-specialty Clinic, 1010 Spruce St, Espanola, NM 87532 Phone: 505-367-0340 Fax: 505-367-0346 | |
Yolanda Martinez-salazar, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 Spruce St, Espanola Multi-specialty Clinic, Espanola, NM 87532 Phone: 505-367-0340 Fax: 505-367-0346 | |
Dr. Steven D Jones, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 Spruce St, Espanola, NM 87532 Phone: 505-747-4144 Fax: 505-747-3213 |